| Literature DB >> 32245530 |
Noah Y Mahpour1, Lauren Pioppo-Phelan1, Mishal Reja1, Augustine Tawadros1, Vinod K Rustgi2.
Abstract
Pharmacologic management of hepatic encephalopathy includes a broad range of therapies. This article covers the specific mainstays of therapies, such as antimicrobials and laxatives, with an established evidence base. This article also covers newer modalities of therapies, such as fecal microbiota transplant, probiotics, bioartificial support systems, small molecular therapies such as l-ornithine l-aspartate, branched chain amino acids, l-carnitine, zinc, and other forms of therapy currently under review.Entities:
Keywords: Acarbose; Branched chain amino acid; FMT; Lactulose; Ornithine phenylacetate; Zinc; l-carnitine; l-ornithine l-aspartate
Mesh:
Substances:
Year: 2020 PMID: 32245530 DOI: 10.1016/j.cld.2020.01.005
Source DB: PubMed Journal: Clin Liver Dis ISSN: 1089-3261 Impact factor: 6.126